The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital.

CEO Steven Gourlay, joins The Market Online to discuss the company’s development.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

acw by the numbers
More From The Market Online

Eastern Gas Corporation jumps on strong gas shows at Macalister

Eastern Gas Corporation has obtained positive gas hits from drilling of the Venus-2H horizontal appraisal well…

Pro Medicus signs $25M contract with US-based Valley Health

Pro Medicus' US subsidiary Visage Imaging has signed a seven-year, $25 million contract with Valley Health…

Noble Helium expanding portfolio with move to acquire Earth Source Hydrogen

Noble Helium has entered into a binding agreement to acquire 100% of the issued share capital…

Janison Education Group secures landmark UK contract with NFER

Janison Education Group has been named as principal technology subcontractor under a major Scottish government contract.